Pharmaceutical composition and its preparation method and use
A composition and drug technology, applied in the field of pharmaceutical composition and its preparation, can solve the problems of self-assembled polypeptide hydrogel skin wound healing and hair follicle regeneration that have not been reported
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0062] The cytocompatibility of the self-assembled polypeptide hydrogel was determined using human mesenchymal stem cells (MSC), as follows:
[0063] (1) Polypeptide synthesis is carried out by using a solid-phase synthesis method, and the peptide molecule is synthesized by a peptide synthesizer. The N-terminal and C-terminal of the peptide chain are modified by acetylation and amidation to prevent its rapid degradation. The synthesized polypeptide RADA16-I (Ac-RADARADARADARADA-CONH 2 ) and PRG (Ac-(RADA) 4 GPRGDSGYRGDS-CONH 2 ) was purified by HPLC, and freeze-dried to obtain RADA16-I and PRG polypeptide freeze-dried powders respectively.
[0064] (2) Dissolve the RADA16-I and PRG polypeptide freeze-dried powders prepared in step (1) with deionized water respectively to obtain RADA16-I solutions with polypeptide concentrations of 1g / 100mL, 0.5g / 100mL, and 0.1g / 100mL and PRG solution, and then, use a 0.22 μm filter membrane to filter and sterilize to obtain sterile RADA16-I...
Embodiment 2
[0074] (1) Polypeptide synthesis is carried out by using a solid-phase synthesis method, and the peptide molecule is synthesized by a peptide synthesizer. The N-terminal and C-terminal of the peptide chain are modified by acetylation and amidation to prevent its rapid degradation. The synthesized polypeptide RADA16-I (Ac-RADARADARADARADA-CONH 2 ) and PRG (Ac-(RADA) 4 GPRGDSGYRGDS-CONH 2 ) was purified by HPLC, and freeze-dried to obtain RADA16-I and PRG polypeptide freeze-dried powders respectively.
[0075] (2) Dissolve the RADA16-I and PRG polypeptide freeze-dried powders prepared in step (1) with deionized water respectively to obtain RADA16-I solution and PRG solution with a polypeptide concentration of 1g / 100mL, and then use 0.22 μm Sterilize with a filter membrane to obtain sterile RADA16-I solution and PRG solution.
[0076] (3) Sonicate the sterile RADA16-I solution and PRG solution for 30 minutes respectively.
[0077] (4) Mix the sonicated RADA16-I solution and t...
Embodiment 3
[0089] (1) Polypeptide synthesis is carried out by using a solid-phase synthesis method, and the peptide molecule is synthesized by a peptide synthesizer. The N-terminal and C-terminal of the peptide chain are modified by acetylation and amidation to prevent its rapid degradation. The synthesized polypeptide RADA16-I (Ac-RADARADARADARADA-CONH 2 ) and PRG (Ac-(RADA) 4 GPRGDSGYRGDS-CONH 2 ) was purified by HPLC, and freeze-dried to obtain RADA16-I and PRG polypeptide freeze-dried powders respectively.
[0090] (2) Dissolve the RADA16-I and PRG polypeptide freeze-dried powders prepared in step (1) with deionized water respectively to obtain RADA16-I solution and PRG solution with a polypeptide concentration of 1g / 100mL, and then use 0.22 μm Membrane filter sterilization to obtain sterile RADA16-I solution and PRG solution.
[0091] (3) Sonicate the sterile RADA16-I solution and PRG solution for 30 minutes respectively.
[0092] (4) Mix the sonicated RADA16-I solution and the ...
PUM
| Property | Measurement | Unit |
|---|---|---|
| concentration | aaaaa | aaaaa |
| concentration | aaaaa | aaaaa |
| water absorption | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 


